Parkinson's disease is the most common neurodegenerative movement disorder. Mutations in PINK1 and PARKIN are the most frequent causes of recessive Parkinson's disease. However, their molecular contribution to pathogenesis remains unclear. Here, we reveal important mechanistic steps of a PINK1/Parkin-directed pathway linking mitochondrial damage, ubiquitylation and autophagy in non-neuronal and neuronal cells. PINK1 kinase activity and its mitochondrial localization sequence are prerequisites to induce translocation of the E3 ligase Parkin to depolarized mitochondria. Subsequently, Parkin mediates the formation of two distinct poly-ubiquitin chains, linked through Lys 63 and Lys 27. In addition, the autophagic adaptor p62/SQSTM1 is recruited to mitochondrial clusters and is essential for the clearance of mitochondria. Strikingly, we identified VDAC1 (voltage-dependent anion channel 1) as a target for Parkin-mediated Lys 27 poly-ubiquitylation and mitophagy. Moreover, pathogenic Parkin mutations interfere with distinct steps of mitochondrial translocation, ubiquitylation and/or final clearance through mitophagy. Thus, our data provide functional links between PINK1, Parkin and the selective autophagy of mitochondria, which is implicated in the pathogenesis of Parkinson's disease.
Mutations in the ␣-synuclein (␣SYN) gene are associated with rare cases of familial Parkinson's disease, and ␣SYN is a major component of Lewy bodies and Lewy neurites. Here we have investigated the localization of wild-type and mutant [A30P]␣SYN as well as SYN at the cellular and subcellular level. Our direct comparative study demonstrates extensive synaptic colocalization of ␣SYN and SYN in human and mouse brain. In a sucrose gradient equilibrium centrifugation assay, a portion of SYN floated into lower density fractions, which also contained the synaptic vesicle marker synaptophysin. Likewise, wild-type and [A30P]␣SYN were found in floating fractions. Subcellular fractionation of mouse brain revealed that both ␣SYN and SYN were present in synaptosomes. In contrast to synaptophysin, SYN and ␣SYN were recovered from the soluble fraction upon lysis of the synaptosomes. (Surguchov et al., 1999). The central domain of ␣SYN had been originally identified as the non-amyloid -protein component (NAC) of Alzheimer's disease plaques (Uéda et al., 1993). Full-length ␣SYN has been subsequently found in Lewy bodies (LBs), pale bodies, and Lewy neurites of patients with Parkinson's disease (PD) and dementia with LBs, as well as in cytoplasmic inclusions characteristic for multiple system atrophy (Spillantini et al., 1997;Arima et al., 1998;Baba et al., 1998;Spillantini et al., 1998;Takeda et al., 1998a;Tu et al., 1998;Wakabayashi et al., 1998;Culvenor et al., 1999). LBs were ␣SYN-positive in LB variant of Alzheimer's disease, familial Alzheimer's disease, and Down's syndrome (Lippa et al., 1998(Lippa et al., , 1999Takeda et al., 1998b), as well as in neurodegeneration with brain iron accumulation type 1 (formerly known as HallervordenSpatz disease) (Arawaka et al., 1998;Wakabayashi et al., 1999).Two missense mutations in the ␣SYN gene have been linked to familial PD (Polymeropoulos et al., 1997;Krüger et al., 1998). Both mutations accelerated the intrinsic property of ␣SYN to selfaggregate into fibrils that were morphologically similar to those isolated from LBs (Conway et al., 1998;Giasson et al., 1999;Narhi et al., 1999). Therefore, similar to most of the mutations associated with other familial forms of neurodegenerative disorders, ␣SYN mutations lead to the abnormal generation of an amyloidogenic variant, which is deposited in the disease-specific lesion (Hardy and Gwinn-Hardy, 1998;Lansbury, 1999;Selkoe, 1999).The physiological function of synucleins is unknown. Targeted disruption of the ␣SYN gene in mice caused a subtle perturbation in dopaminergic neurotransmission (Abeliovich et al., 2000). The identification of ␣SYN binding proteins has pointed to potential roles in signal transduction, perhaps in the context of axonal transport (Jenco et al., 1998;Engelender et al., 1999;Jensen et al., 1999;Ostrerova et al., 1999). Another link to signal transduction events may be indicated by the fact that both ␣SYN and SYN are phosphorylated Okochi et al., 2000).Previous immunohistochemical studies suggested an enrichme...
Degeneration of dopaminergic neurons in the substantia nigra is characteristic for
␣-Synuclein has been implicated in the pathogenesis of Parkinson's disease, since rare autosomal dominant mutations are associated with early onset of the disease and ␣-synuclein was found to be a major constituent of Lewy bodies. We have analyzed ␣-synuclein expression in transfected cell lines. In pulse-chase experiments ␣-synuclein appeared to be stable over long periods (t1 ⁄2 54 h) and no endoproteolytic processing was observed. ␣-Synuclein was constitutively phosphorylated in human kidney 293 cells as well as in rat pheochromocytoma PC12 cells. In both cell lines phosphorylation was highly sensitive to phosphatases, since okadaic acid markedly stabilized phosphate incorporation. Phosphoamino acid analysis revealed that phosphorylation occurred predominantly on serine. Using site-directed mutagenesis we have identified a major phosphorylation site at serine 129 within the C-terminal domain of ␣-synuclein. An additional site, which was phosphorylated less efficiently, was mapped to serine 87. The major phosphorylation site was located within a consensus recognition sequence of casein kinase 1 (CK-1). In vitro experiments and two-dimensional phosphopeptide mapping provided further evidence that serine 129 was phosphorylated by CK-1 and CK-2. Moreover, phosphorylation of serine 129 was reduced in vivo upon inhibition of CK-1 or CK-2. These data demonstrate that ␣-synuclein is constitutively phosphorylated within its C terminus and may indicate that the function of ␣-synuclein is regulated by phosphorylation/dephosphorylation.
(Oligodendro)glial cytoplasmic inclusions composed of α-synuclein (αSYN) characterize multiple system atrophy (MSA). Mature oligodendrocytes (OLs) do not normally express αSYN, so MSA pathology may arise from aberrant expression of αSYN in OLs. To study pathological deposition of αSYN in OLs, transgenic mice were generated in which human wild-type αSYN was driven by a proteolipid protein promoter. Transgenic αSYN was detected in OLs but no other brain cell type. At the light microscopic level, the transgenic αSYN profiles resembled glial cytoplasmic inclusions. Strikingly, the diagnostic hyperphosphorylation at S129 of αSYN was reproduced in the transgenic mice. A significant proportion of the transgenic αSYN was detergent insoluble, as in MSA patients. The histological and biochemical abnormalities were specific for the disease-relevant αSYN because control green fluorescent protein was fully soluble and evenly distributed throughout OL cell bodies and processes. Thus, ectopic expression αSYN in OLs might initiate salient features of MSA pathology.
A number of neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy, are characterized by the intracellular deposition of fibrillar aggregates that contain a high proportion of ␣-synuclein (␣S). The interaction with the membrane-water interface strongly modulates folding and aggregation of the protein. The present study investigates the lipid binding and the coil-helix transition of ␣S, using titration calorimetry, differential scanning calorimetry, and circular dichroism spectroscopy. Titration of the protein with small unilamellar vesicles composed of zwitterionic phospholipids below the chain melting temperature of the lipids yielded exceptionally large exothermic heat values. The sigmoidal titration curves were evaluated in terms of a simple model that assumes saturable binding sites at the vesicle surface. The cumulative heat release and the ellipticity were linearly correlated as a result of simultaneous binding and helix folding. There was no heat release and folding of ␣S in the presence of large unilamellar vesicles, indicating that a small radius of curvature is necessary for the ␣S-membrane interaction. The heat release and the negative heat capacity of the proteinvesicle interaction could not be attributed to the coilhelix transition of the protein alone. We speculate that binding and helix folding of ␣S depends on the presence of defect structures in the membrane-water interface, which in turn results in lipid ordering in the highly curved vesicular membranes. This will be discussed with regard to a possible role of the protein for the stabilization of synaptic vesicle membranes. ␣-Synuclein (␣S)1 is a protein of 140 amino acids that has been identified as a major component of the intracytoplasmic fibrillar deposits (Lewy bodies) associated with idiopathic and inherited forms of Parkinson's disease (1). The majority of cases are idiopathic, whereas mutations in the ␣S gene are known to be responsible for rare inherited, early onset variants of Parkinson's disease (2-4). Although the molecular mode of action of ␣S and of its homologs is as yet unknown, it was assumed that the protein modulates the dopamine neurotransmission by regulating synaptic vesicle (SV) mobilization from the presynaptic reserve pool (5, 6) or directly regulating the dopamine metabolism (7-9). However, attempts to identify a specific SV-binding protein, e.g. by protein cross-linking, have been unsuccessful so far.At a certain threshold concentration, ␣S tends to aggregate into amyloid fibrils (10), whereas the homolog S, which lacks a stretch of amino acids within the central portion of ␣S, has a much lower fibrillization propensity (11, 12) and may even inhibit ␣S fibrillization (13-15), indicating that the hydrophobic central part of ␣S is essential for its fibrillar aggregation (16). A recent study on the structure of mature fibrillar aggregates, using site-directed spin labeling, indicates that the N terminus of ␣S is less ordered than the central portion and that t...
Phosphorylation of ␣-synuclein (␣-syn) at Ser-129 is a hallmark of Parkinson disease and related synucleinopathies. However, the identity of the natural kinases and phosphatases responsible for regulating ␣-syn phosphorylation remain unknown. Here we demonstrate that three closely related members of the human Polo-like kinase (PLK) family (PLK1, PLK2, and PLK3) phosphorylate ␣-syn and -syn specifically at Ser-129 and Ser-118, respectively. Unlike other kinases reported to partially phosphorylate ␣-syn at Ser-129 in vitro, phosphorylation by PLK2 and PLK3 is quantitative (>95% conversion). Only PLK1 and PLK3 phosphorylate -syn at Ser-118, whereas no phosphorylation of ␥-syn was detected by any of the four PLKs (PLK1 to -4). PLK-mediated phosphorylation was greatly reduced in an isolated C-terminal fragment (residues 103-140) of ␣-syn, suggesting substrate recognition via the N-terminal repeats and/or the non-amyloid component domain of ␣-syn. PLKs specifically co-localized with phosphorylated Ser-129 (Ser(P)-129) ␣-syn in various subcellular compartments (cytoplasm, nucleus, and membranes) of mammalian cell lines and primary neurons as well as in ␣-syn transgenic mice, especially cortical brain areas involved in synaptic plasticity. Furthermore, we report that the levels of PLK2 are significantly increased in brains of Alzheimer disease and Lewy body disease patients. Taken together, these results provide biochemical and in vivo evidence of ␣-syn and -syn phosphorylation by specific PLKs. Our results suggest a need for further studies to elucidate the potential role of PLK-syn interactions in the normal biology of these proteins as well as their involvement in the pathogenesis of Parkinson disease and other synucleinopathies.Increasing evidence suggests that phosphorylation may play an important role in the oligomerization and fibrillogenesis (1), Lewy body formation (1, 2) and neurotoxicity of ␣-synuclein (␣-syn) 5 in vivo (3). The majority of ␣-syn within Lewy bodies (LBs) in diseased human brains and animal models of Parkinson disease (PD) and related synucleinopathies is phosphorylated at Ser-129 (Ser(P)-129) (1, 2, 4 -7). Although recent studies support the notion that phosphorylation at Ser-129 is related to pathology and blocks ␣-syn fibrillization in vitro (8, 9), the exact mechanisms by which phosphorylation at Ser-129 modulates ␣-syn aggregation and toxicity in vivo remain elusive. Unraveling the role of phosphorylation in modulating the physiological and pathogenic activities of ␣-syn requires identification of the kinases and phosphatases involved in regulating its phosphorylation in vivo.Several kinases that phosphorylate ␣-syn at serine and tyrosine residues, primarily in its C-terminal region, have been identified using in vitro kinase assays and co-transfection studies. Casein kinase I and II, G-protein-coupled receptor kinases (GRK1, GRK2, GRK5, and GRK6), and calmodulin-dependent kinase II (10 -12) phosphorylate ␣-syn at Ser-129. Ser-87 is the only residue outside the C-terminal region report...
BackgroundMitochondrial dysfunction and degradation takes a central role in current paradigms of neurodegeneration in Parkinson's disease (PD). Loss of DJ-1 function is a rare cause of familial PD. Although a critical role of DJ-1 in oxidative stress response and mitochondrial function has been recognized, the effects on mitochondrial dynamics and downstream consequences remain to be determined.Methodology/Principal FindingsUsing DJ-1 loss of function cellular models from knockout (KO) mice and human carriers of the E64D mutation in the DJ-1 gene we define a novel role of DJ-1 in the integrity of both cellular organelles, mitochondria and lysosomes. We show that loss of DJ-1 caused impaired mitochondrial respiration, increased intramitochondrial reactive oxygen species, reduced mitochondrial membrane potential and characteristic alterations of mitochondrial shape as shown by quantitative morphology. Importantly, ultrastructural imaging and subsequent detailed lysosomal activity analyses revealed reduced basal autophagic degradation and the accumulation of defective mitochondria in DJ-1 KO cells, that was linked with decreased levels of phospho-activated ERK2.Conclusions/SignificanceWe show that loss of DJ-1 leads to impaired autophagy and accumulation of dysfunctional mitochondria that under physiological conditions would be compensated via lysosomal clearance. Our study provides evidence for a critical role of DJ-1 in mitochondrial homeostasis by connecting basal autophagy and mitochondrial integrity in Parkinson's disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.